SYNERGY passed the drug GMP compliance inspection
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, SYNERGY announced that the company recently received the "Notice of Inspection Results for Drug GMP Compliance from the Jiangxi Provincial Drug Administration (Gan Drug GMP (2025) No. A0020)." It was learned that through on-site inspection and comprehensive assessment, the raw material drug Empagliflozin complies with drug GMP. Empagliflozin is suitable for the treatment of type 2 diabetes
According to the Zhitong Finance APP, SYNERGY (300636.SZ) announced that it recently received the "Notice of Compliance Inspection Results for Drug GMP from the Jiangxi Provincial Drug Administration (Gan Drug GMP (2025) No. A0020)." It was learned that through on-site inspection and comprehensive assessment, the company's raw material drug Empagliflozin complies with drug GMP. Empagliflozin is used for the treatment of type 2 diabetes